Cary P Gross

Author PubWeight™ 193.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003 16.08
2 Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004 14.05
3 Are racial and ethnic minorities less willing to participate in health research? PLoS Med 2005 7.88
4 Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity. J Clin Oncol 2014 6.62
5 Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002 4.45
6 Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011 4.07
7 Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst 2012 3.72
8 Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol 2012 3.34
9 Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J 2003 3.11
10 Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol 2012 3.07
11 Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota. JAMA 2007 3.03
12 Recruiting vulnerable populations into research: a systematic review of recruitment interventions. J Gen Intern Med 2007 3.02
13 Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 2006 2.69
14 Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology. Int J Radiat Oncol Biol Phys 2010 2.66
15 The relationship between clinical benefit and receipt of curative therapy for prostate cancer. Arch Intern Med 2012 2.48
16 Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 2007 2.46
17 Effect of blinded peer review on abstract acceptance. JAMA 2006 2.38
18 The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care 2011 2.38
19 Sharing of clinical trial data among trialists: a cross sectional survey. BMJ 2012 2.31
20 Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med 2006 2.29
21 Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Coll Cardiol 2012 2.18
22 The importance of clinical trial data sharing: toward more open science. Circ Cardiovasc Qual Outcomes 2012 2.16
23 Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology 2013 2.16
24 Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care 2014 2.14
25 Derivation and validation of a clinical prediction rule for uncomplicated ureteral stone--the STONE score: retrospective and prospective observational cohort studies. BMJ 2014 2.06
26 NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) 2009 2.01
27 Anesthesiologist involvement in screening colonoscopy: temporal trends and cost implications in the medicare population. Clin Gastroenterol Hepatol 2011 1.97
28 Use of hospital-based acute care among patients recently discharged from the hospital. JAMA 2013 1.88
29 Physician violations of online professionalism and disciplinary actions: a national survey of state medical boards. JAMA 2012 1.81
30 Validation of the partin nomogram for prostate cancer in a national sample. J Urol 2010 1.64
31 Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database. J Urol 2010 1.64
32 Laparoscopic colectomy for the treatment of cancer has been widely adopted in the United States. Dis Colon Rectum 2012 1.62
33 Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population. Arch Dermatol 2012 1.60
34 Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes. Leuk Res 2009 1.57
35 Geographical information systems: applications and limitations in oncology research. Oncology (Williston Park) 2011 1.52
36 Validity of a simple ST-elevation acute myocardial infarction risk index: are randomized trial prognostic estimates generalizable to elderly patients? Circulation 2003 1.50
37 Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care. Med Care 2014 1.50
38 A randomized outpatient trial of a decision-support information technology tool. Arch Intern Med 2005 1.49
39 Promoting transparency in pharmaceutical industry-sponsored research. Am J Public Health 2011 1.46
40 A historic moment for open science: the Yale University Open Data Access project and medtronic. Ann Intern Med 2013 1.45
41 Effectiveness of radiation therapy in older women with ductal carcinoma in situ. J Natl Cancer Inst 2006 1.44
42 Hospital-level outcomes associated with laparoscopic colectomy for cancer in the minimally invasive era. J Gastrointest Surg 2012 1.43
43 Impact of comorbidity on mortality among older persons with advanced heart failure. J Gen Intern Med 2011 1.31
44 The shortage of on-call surgical specialist coverage: a national survey of emergency department directors. Acad Emerg Med 2010 1.27
45 Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2012 1.25
46 Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Circulation 2005 1.24
47 Polypharmacy in older adults with cancer. Oncologist 2010 1.23
48 Online professionalism investigations by state medical boards: first, do no harm. Ann Intern Med 2013 1.18
49 Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009. Cancer 2014 1.18
50 The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population. J Urol 2011 1.16
51 Contribution of individual diseases to death in older adults with multiple diseases. J Am Geriatr Soc 2012 1.15
52 Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Heart Assoc 2014 1.14
53 Multilevel interventions: study design and analysis issues. J Natl Cancer Inst Monogr 2012 1.13
54 Integrating teaching skills and clinical content in a faculty development workshop. J Gen Intern Med 2003 1.09
55 Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by region, as if set by thermostat. Health Aff (Millwood) 2012 1.09
56 Renal ultrasonography in the evaluation of acute kidney injury: developing a risk stratification framework. Arch Intern Med 2010 1.08
57 Risks and benefits associated with novel phase 1 oncology trial designs. Cancer 2007 1.07
58 Sea change in open science and data sharing: leadership by industry. Circ Cardiovasc Qual Outcomes 2014 1.05
59 Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 2003 1.01
60 Associations between mental health and surgical outcomes among women undergoing mastectomy for cancer. Breast J 2013 1.00
61 The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications. Int J Radiat Oncol Biol Phys 2012 1.00
62 Change in comorbidity prevalence with advancing age among persons with heart failure. J Gen Intern Med 2011 1.00
63 A method for partitioning the attributable fraction of multiple time-dependent coexisting risk factors for an adverse health outcome. Am J Public Health 2012 1.00
64 Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries. Arch Intern Med 2012 0.99
65 Predictors of venous thromboembolism in patients with advanced common solid cancers. J Cancer Epidemiol 2010 0.98
66 Use of postmastectomy radiotherapy in older women. Int J Radiat Oncol Biol Phys 2007 0.98
67 Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment. J Am Geriatr Soc 2014 0.97
68 Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States. Cancer Causes Control 2009 0.96
69 Outcomes of referral to dermatology for suspicious lesions: implications for teledermatology. Arch Dermatol 2011 0.96
70 The cost implications of prostate cancer screening in the Medicare population. Cancer 2013 0.95
71 Medical respite programs for homeless patients: a systematic review. J Health Care Poor Underserved 2013 0.95
72 Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol 2006 0.93
73 Media exposure and tobacco, illicit drugs, and alcohol use among children and adolescents: a systematic review. Subst Abus 2010 0.92
74 Radiosurgery alone for 5 or more brain metastases: expert opinion survey. J Neurosurg 2010 0.91
75 Gender differences in the ability to identify a mentor at morning report: a multi-institutional survey. Teach Learn Med 2002 0.91
76 Older patient experiences in the mammography decision-making process. Arch Intern Med 2012 0.91
77 Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes. Leuk Res 2010 0.91
78 Screening colonoscopy use among individuals at higher colorectal cancer risk. J Clin Gastroenterol 2006 0.91
79 Geographic analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys 2011 0.91
80 Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study. Am Heart J 2003 0.90
81 Variation in receipt of radiation therapy after breast-conserving surgery: assessing the impact of physicians and geographic regions. Med Care 2013 0.89
82 Use of new treatment modalities for non-small cell lung cancer care in the Medicare population. Chest 2013 0.89
83 Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer. Breast Cancer Res Treat 2013 0.87
84 Age-based and sex-based disparities in screening colonoscopy use among medicare beneficiaries. J Clin Gastroenterol 2013 0.87
85 Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012 0.87
86 A new approach to understanding racial disparities in prostate cancer treatment. J Geriatr Oncol 2013 0.84
87 Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer. J Natl Cancer Inst 2014 0.84
88 Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey. Trials 2014 0.84
89 Policy research: using evidence to improve healthcare delivery systems. Circulation 2009 0.83
90 Access to experimental drugs for terminally ill patients. JAMA 2008 0.83
91 The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes. Leuk Res 2012 0.82
92 Hospital readmissions and emergency department visits following laparoscopic and open colon resection for cancer. Dis Colon Rectum 2013 0.82
93 The Effect of the Diffusion of the Surgical Robot on the Hospital-level Utilization of Partial Nephrectomy. Med Care 2015 0.81
94 Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer. Ann Thorac Surg 2012 0.81
95 A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer. BJU Int 2014 0.81
96 Cognitive effects of hormonal therapy in older adults. Semin Oncol 2008 0.81
97 Is the use of preoperative breast MRI resulting in more invasive breast cancer surgery? Womens Health (Lond Engl) 2014 0.80
98 Effect of β-blockers on cardiac and pulmonary events and death in older adults with cardiovascular disease and chronic obstructive pulmonary disease. Med Care 2014 0.80
99 Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy. Pharmacoepidemiol Drug Saf 2012 0.80
100 Building a bridge to somewhere better: linking health care research and health policy. Health Serv Res 2012 0.79
101 Use of complementary medications among older adults with cancer. Cancer 2012 0.79
102 The cost of breast cancer screening in the United States: a picture is worth ... a billion dollars? Ann Intern Med 2014 0.79
103 Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival. Breast Cancer Res Treat 2014 0.79
104 End-of-Life Care Intensity and Hospice Use: A Regional-level Analysis. Med Care 2016 0.78
105 Impact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific Incidence. Am J Clin Oncol 2016 0.78
106 Hospital-based acute care after outpatient colonoscopy: implications for quality measurement in the ambulatory setting. Med Care 2014 0.78
107 Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer. J Thorac Oncol 2012 0.78
108 Adherence reporting in randomized controlled trials. Clin Trials 2013 0.78
109 Association of type of renal surgery and access to robotic technology for kidney cancer: results from a population-based cohort. BJU Int 2014 0.78
110 Improving clinical productivity in the academic setting: a novel incentive plan based on utility theory. Acad Med 2006 0.77
111 Self-reported distress after cognitive testing in patients with Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2008 0.77
112 Reply to L.W. Cuttino et al. J Clin Oncol 2013 0.77
113 CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer. Int J Gynecol Cancer 2013 0.77
114 Quality of cancer survivorship care in the military health system (TRICARE). Cancer J 2013 0.76
115 County-level association of melanoma and papillary thyroid cancer: evidence of shared environmental risk? Pigment Cell Melanoma Res 2014 0.75
116 Response. J Natl Cancer Inst 2013 0.75
117 The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancer. J Geriatr Oncol 2013 0.75
118 The impact of Medicaid coverage and reimbursement on access to diagnostic mammography. Cancer 2009 0.75
119 Economic Impact of Routine Cavity Margins Versus Standard Partial Mastectomy in Breast Cancer Patients: Results of a Randomized Controlled Trial. Ann Surg 2017 0.75
120 Regional Medicare Expenditures and Survival Among Older Women With Localized Breast Cancer. Med Care 2017 0.75
121 Is the tobacco settlement constitutional? J Law Med Ethics 2006 0.75
122 The Relationship Between Geographic Access to Plastic Surgeons and Immediate Breast Reconstruction Rates Among Women Undergoing Mastectomy for Cancer. Plast Reconstr Surg 2015 0.75
123 Determinants of enrollment in cancer clinical trials: the relationship between the current state of knowledge, societal disease burden, and randomized clinical trial enrollment. J Natl Compr Canc Netw 2013 0.75
124 The Relationship Between Geographic Access to Plastic Surgeons and Breast Reconstruction Rates Among Women Undergoing Mastectomy for Cancer. Ann Plast Surg 2017 0.75
125 Nondermatologists' use of predictive terms for a potentially malignant lesion. South Med J 2011 0.75
126 Facilitating Meaningful Engagement on Community Advisory Committees in Patient-Centered Outcome Research. Prog Community Health Partnersh 2017 0.75
127 Moving reform to the bedside: involvement of individual physicians. JAMA 2010 0.75
128 Association of physician specialty and medical therapy for benign prostatic hyperplasia. Med Care 2014 0.75